|
Patient No.#
|
Date of Isolation day/month/year
|
Specimen Obtained
|
MIC(μg/ml)
|
|---|
| |
PIPC
|
CAZ
|
CFS
|
CFPM
|
CZOP
|
AZT
|
IPM
|
MEPM
|
TOB
|
AMK
|
GM
|
MINO
|
LVFX
|
CPFX
|
ST
|
FOM
|
C/S
|
P/T
|
|
P-A
|
07/09/2010
|
bronchial aspirate
|
> 64
|
> 16
|
> 16
|
> 16
|
> 16
|
> 16
|
> 8
|
< 1
|
> 8
|
> 32
|
> 8
|
< 2
|
2
|
2
|
< 2
|
> 16
|
> 32
|
< 8
|
|
P-B
|
13/09/2010
|
salivary fluid
|
64
|
4
|
> 16
|
> 16
|
> 16
|
> 16
|
> 8
|
2
|
> 8
|
> 32
|
> 8
|
4
|
4
|
> 2
|
> 2
|
> 16
|
> 32
|
< 8
|
|
P-5
|
14/09/2010
|
bronchial aspirate
|
> 64
|
4
|
> 16
|
> 16
|
> 16
|
> 16
|
> 8
|
< 1
|
> 8
|
> 32
|
> 8
|
< 2
|
1
|
1
|
< 2
|
> 16
|
> 32
|
< 8
|
|
P-6a
|
21/09/2010
|
peripheral blood
|
> 64
|
4
|
> 16
|
> 16
|
> 16
|
> 16
|
8
|
< 1
|
> 8
|
> 32
|
> 8
|
< 2
|
1
|
1
|
< 2
|
> 16
|
> 32
|
< 8
|
|
P-6b
|
12/10/2010
|
catheterized urine
|
> 64
|
8
|
> 16
|
> 16
|
> 16
|
> 16
|
8
|
< 1
|
> 8
|
> 32
|
> 8
|
< 2
|
1
|
1
|
< 2
|
> 16
|
> 32
|
< 8
|
|
P-7
|
14/09/2010
|
bronchial aspirate
|
64
|
8
|
> 16
|
> 16
|
> 16
|
> 16
|
> 8
|
< 1
|
> 8
|
> 32
|
> 8
|
< 2
|
1
|
1
|
< 2
|
> 16
|
> 32
|
< 8
|
|
P-8
|
28/09/2010
|
bronchial aspirate
|
> 64
|
4
|
> 16
|
> 16
|
> 16
|
> 16
|
8
|
< 1
|
> 8
|
> 32
|
> 8
|
< 2
|
1
|
1
|
< 2
|
> 16
|
> 32
|
< 8
|
|
P-9
|
18/01/2011
|
bronchial aspirate
|
64
|
8
|
> 16
|
> 16
|
> 16
|
> 16
|
8
|
< 1
|
> 8
|
> 32
|
> 8
|
< 2
|
< 0.5
|
0.5
|
< 2
|
> 16
|
> 32
|
< 8
|
- PIPC: piperacillin, CAZ: ceftazidime, CFS: cefsulodin, CFPM: cefepime, CZOP: cefozopran, AZT: aztreonam, IPM: imipenem, MEPM: meropenem, TOB: tobramycin AMK: amikacin, GM: gentamicin, MINO: minocycline, LVFX: levofloxacin,, CPFX: ciprofloxacin, ST: sulfamethoxazole/trimethoprim, FOM: fosfomycin, C/S: cefoperazone/sulbactam, P/T: piperacillin/tazobactam #: P-A: Patient a, P-B: Patient B, both hospitalized in different wards unrelated to the NICU. as for P-5, -6, -7, -8, and -9, see text in the Results section, for the backgrounds of the isolates.
